Fundz

Gamida Cell Announces Entry Into Commitment Letter With Highbridge For $25 Million Financing

PRIVATESep 28, 2022

Amount Raised

$25 Million

Round Type

Funding Round

BostonBiotechnologyHealth CareMedicalTherapeutics

Description

Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, announced that it has entered into a Commitment Letter with certain funds managed by Highbridge Capital Management, LLC (“Highbridge”), pursuant to which Highbridge has committed to provide a $25 million senior secured, convertible term loan (the “term loan”).

Quick answer

Gamida Cell raised $25 Million in a Funding Round round, dated September 28, 2022. Gamida Cell is based in Boston, Massachusetts, United States.

How much did Gamida Cell raise?
Gamida Cell raised $25 Million in a Funding Round round on September 28, 2022.
What does Gamida Cell do?
Gamida Cell is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumor and blood cancers and other serious blood diseases.
Where is Gamida Cell based and how big is it?
Gamida Cell is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Gamida Cell that raised within 45 days of this round, from Fundz verified event records.

  • NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
  • Novadip Biosciences raised $39M (Funding Round) on November 4, 2022.
  • Qnovia raised $17M (Series A) on September 28, 2022.
  • Abivax raised $49M (Funding Round) on September 2, 2022.
  • Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
  • NRG Therapeutics raised $18M (Series A) on November 9, 2022.

Who to call at Gamida Cell, and when

A new round usually means Gamida Cell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gamida Cell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gamida Cell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gamida Cell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gamida Cell

Location

Boston, Massachusetts, United States

About

Gamida Cell is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumor and blood cancers and other serious blood diseases. We apply a proprietary expansion platform leveraging the properties of NAM to allogeneic cell sources including umbilical cord blood-derived cells and NK cells to create therapy candidates with potential to redefine standards of care. These include omidubicel, an investigational product with potential as a life-saving alternative for patients in need of bone marrow transplant, and a line of modified and unmodified NAM-enabled NK cells targeted at solid tumor and hematological malignancies. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn, Twitter, Facebook or Instagram at @GamidaCellTx.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gamida Cell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Gamida Cell's next move

See what Strategic adds

Gamida Cell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.